Ignite Creation Date:
2025-12-25 @ 3:26 AM
Ignite Modification Date:
2025-12-26 @ 2:06 AM
Study NCT ID:
NCT04678505
Status:
TERMINATED
Last Update Posted:
2022-11-04
First Post:
2020-12-16
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Study of a Single Intravenous (IV) Dose of MK-3402 in Participants With Impaired Renal Function and in Healthy Controls (MK-3402-004)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-02-10
Start Date Type:
ACTUAL
Primary Completion Date:
2021-04-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-04-27
Completion Date Type:
ACTUAL
First Submit Date:
2020-12-16
First Submit QC Date:
None
Study First Post Date:
2020-12-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-04-05
Results First Submit QC Date:
None
Results First Post Date:
2022-11-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-05
Last Update Post Date:
2022-11-04
Last Update Post Date Type:
ACTUAL